We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Needs Better Patient Data to Regulate Stronger Opioids, Experts Say
FDA Needs Better Patient Data to Regulate Stronger Opioids, Experts Say
The FDA needs more data on the likely impact on patients before it introduces tighter controls on high-strength opioids and doses for outpatient settings, the agency heard in a two-day public meeting.